PVC Adverse Event Reporting & Case Management 3 — Questions and Answers
Question 1: A company receives an adverse event report from a published scientific journal article. What is the 'clock start' date for reporting purposes?
- The date the article was originally published in the journal
- The date any company employee first becomes aware of the report containing minimum case criteria (Correct answer)
- The date the medical reviewer completes the causality assessment
- The date the case is entered into the safety database
Correct answer: The date any company employee first becomes aware of the report containing minimum case criteria
Day 0 (clock start) is the date any employee of the company — in any department — first receives information that meets minimum case criteria, regardless of publication date.
Question 2: Under ICH E2B(R3), in which format must ICSRs be electronically transmitted to regulatory authorities?
- PDF with embedded XML metadata
- HL7 FHIR R4 JSON format
- ICH E2B(R3) XML using the ICSR schema (Correct answer)
- MedDRA-coded CSV with CIOMS I headers
Correct answer: ICH E2B(R3) XML using the ICSR schema
ICH E2B(R3) requires ICSRs to be transmitted as XML files conforming to the ICH ICSR message specification, replacing the earlier E2B(R2) standard.
Question 3: What is the key difference between a 'follow-up' report and an 'amendment' in ICSR case management?
- A follow-up adds new information to an ongoing case; an amendment corrects errors in a previously submitted report (Correct answer)
- A follow-up is submitted to local authorities; an amendment is submitted to international agencies
- A follow-up is required within 7 days; an amendment has no time limit
- A follow-up changes the causality assessment; an amendment changes the seriousness classification
Correct answer: A follow-up adds new information to an ongoing case; an amendment corrects errors in a previously submitted report
A follow-up report provides new or updated clinical information about an existing case, while an amendment corrects factual errors in a previously submitted ICSR.
Question 4: Which coding dictionary is the international standard for classifying adverse event terms in pharmacovigilance reporting?
- ICD-10
- SNOMED CT
- MedDRA (Medical Dictionary for Regulatory Activities) (Correct answer)
- WHO-ART (WHO Adverse Reaction Terminology)
Correct answer: MedDRA (Medical Dictionary for Regulatory Activities)
MedDRA is the internationally agreed medical terminology standard mandated by ICH and regulatory agencies worldwide for coding adverse events in safety reports.
Question 5: A healthcare professional reports that a patient developed severe hepatotoxicity after taking a company's drug. The reporter states 'I think the drug caused this.' How should the company classify causality?
- As unrelated, because the reporter's opinion is not sufficient evidence
- As related, because a healthcare professional's expressed opinion constitutes a positive causality assessment (Correct answer)
- As unknown, pending a full medical review by the company's safety physician
- As possibly related, which is the default for all spontaneous reports
Correct answer: As related, because a healthcare professional's expressed opinion constitutes a positive causality assessment
When a qualified healthcare professional provides a causal opinion connecting a product to an adverse event, this constitutes a positive causality assessment that must be accepted for reporting purposes.
Question 6: In the context of aggregate safety reporting, what is the purpose of a Periodic Benefit-Risk Evaluation Report (PBRER)?
- To summarize clinical trial adverse event data before a product's initial marketing authorization
- To provide a periodic comprehensive benefit-risk evaluation of a marketed product using cumulative safety data (Correct answer)
- To report all expedited ICSRs received in the previous quarter to a single regional authority
- To document pharmacovigilance system master file (PSMF) updates on an annual basis
Correct answer: To provide a periodic comprehensive benefit-risk evaluation of a marketed product using cumulative safety data
The PBRER (replacing the PSUR) provides a cumulative assessment of a marketed product's benefit-risk profile at defined intervals, incorporating all safety data from the data lock point.
Question 7: What does 'expectedness' mean in the context of an adverse event, and which document determines it?
- Whether the event was anticipated by the prescribing physician, as recorded in the patient's chart
- Whether the adverse event is consistent with what is described in the reference safety information (RSI) such as the SmPC or IB (Correct answer)
- Whether the event occurs in more than 1% of patients based on clinical trial data
- Whether the event was reported by more than three independent sources in the literature
Correct answer: Whether the adverse event is consistent with what is described in the reference safety information (RSI) such as the SmPC or IB
Expectedness is determined by comparing the reported adverse event to the Reference Safety Information (RSI) — the SmPC for marketed products or the Investigator's Brochure in clinical trials.
PVC Adverse Event Reporting & Case Management 3
A company receives an adverse event report from a published scientific journal article.
What is the 'clock start' date for reporting purposes?